Global Apheresis Market Size Report Segmented by Product (Devices, Disposables & Consumables), Procedure (Plasmapheresis, Plateletpheresis), Technology (Centrifugation, Membrane Separation), Application (Renal Disorders, Neurological Disorders), Forecast to 2030
The global apheresis market is expected to grow at a CAGR of ~8% during the forecast period. The market expansion is driven by the increasing prevalence of chronic and autoimmune diseases, growing demand for blood components, and advancements in apheresis technologies. Additionally, rising awareness about blood donation is fostering market growth. However, the high cost of apheresis procedures and devices, along with stringent regulatory requirements, pose challenges to market expansion. To learn more about the research report, download a sample report.
Report Overview
Apheresis is a medical procedure that involves the separation of blood components to remove or collect specific elements while returning the remaining blood to the patient. This technique is widely used for therapeutic and donation purposes, including the extraction of plasma, platelets, leukocytes, and red blood cells. In therapeutic apheresis, the procedure is employed to treat conditions such as autoimmune disorders, leukemia, and metabolic diseases by removing pathogenic substances. Additionally, apheresis plays a crucial role in blood banking and transfusion medicine, ensuring the availability of vital blood components for medical treatments.
To learn more about this report, download the PDF brochure
Expanding use of apheresis in chronic disease management
One of the primary factors driving the demand for apheresis is the rising prevalence of chronic diseases, particularly autoimmune disorders, hematologic malignancies, and metabolic conditions. Apheresis is frequently used in treating conditions such as Guillain-Barré syndrome, myasthenia gravis, and thrombotic thrombocytopenic purpura, where conventional treatments may be less effective. The increasing burden of chronic kidney disease (CKD) and cardiovascular disorders has also escalated the demand for therapeutic plasma exchange and LDL apheresis. Furthermore, the expanding applications of apheresis in regenerative medicine and stem cell therapies contribute to its adoption in clinical settings. With the aging population and rising disease burden, healthcare providers are increasingly integrating apheresis as a critical component of patient management, reinforcing its demand across hospitals and specialty clinics.
Advancements in apheresis improving precision and clinical outcomes
Significant technological advancements in apheresis systems are playing a crucial role in market expansion. Innovations such as automation, improved membrane filtration techniques, and software-integrated devices have enhanced the efficiency and safety of apheresis procedures. The introduction of selective apheresis, which allows for the precise removal of specific disease-causing factors, has broadened therapeutic applications. Additionally, the development of portable and point-of-care apheresis devices has improved accessibility, particularly in home healthcare and ambulatory settings. Another major advancement is integrating artificial intelligence (AI) and machine learning (ML) in apheresis systems, enabling real-time monitoring and personalized treatment adjustments. These technological innovations are improving patient outcomes, reducing procedure times, and expanding the scope of apheresis in clinical practice, thereby driving the market forward.
To learn more about this report, download the PDF brochure
Competitive Landscape Analysis
The global apheresis market is marked by the presence of established and emerging market players such as Fresenius SE & Co. KGaA; Haemonetics Corporation; Asahi Kasei Medical Co., Ltd.; Terumo BCT, Inc.; Baxter International Inc.; Becton, Dickinson and Company; Medica S.p.A; B. Braun Melsungen AG; Mallinckrodt Plc; and Nikkiso Co., Ltd. among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.
Report Scope
| Report Metric | Details |
| Base Year Considered | 2024 |
| Historical Data | 2023 – 2024 |
| Forecast Period | 2025 – 2030 |
| Growth Rate | 8% |
| Market Drivers |
|
| Attractive Opportunities |
|
| Segment Scope | Product, Procedure, Technology, Application, and End-user |
| Regional Scope |
|
| Key Companies Mapped | Fresenius SE & Co. KGaA; Haemonetics Corporation; Asahi Kasei Medical Co., Ltd.; Terumo BCT, Inc.; Baxter International Inc.; Becton, Dickinson and Company; Medica S.p.A; B. Braun Melsungen AG; Mallinckrodt Plc; and Nikkiso Co., Ltd. among others |
| Report Highlights | Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis |
Global Apheresis Market Segmentation
This report by Medi-Tech Insights provides the size of the global apheresis market at the regional- and country-level from 2023 to 2030. The report further segments the market based on product, procedure, technology, application and end-user.
Market Size & Forecast (2023-2030), By Product, USD Million
- Devices
- Disposables & Consumables
Market Size & Forecast (2023-2030), By Procedure, USD Million
- Plasmapheresis
- Plateletpheresis
- Leukapheresis
- Photopheresis
- Erythrocytapheresis
- Others
-
Market a& Forecast (2023-2030), By Technology, USD Million
- Centrifugation
- Membrane Separation
Market Size & Forecast (2023-2030), By Application, USD Million
- Renal Disorders
- Neurological Disorders
- Hematological Disorders
- Autoimmune Disorders
- Others
Market Size & Forecast (2023-2030), By End-user, USD Million
- Hospitals
- Blood Banks
- Specialty Clinics
- Others
Market Size & Forecast (2023-2030), By Region, USD Million
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Key Strategic Questions Addressed
- What is the market size & forecast of the apheresis market?
- What are historical, present, and forecasted market shares and growth rates of various segments and sub-segments of the apheresis market?
- What are the key trends defining the market?
- What are the major factors impacting the market?
- What are the opportunities prevailing in the market?
- Which region has the highest share in the global market? Which region is expected to witness the highest growth rate in the next 5 years?
- Who are the major players operating in the market?
- What are the key strategies adopted by players?
- Introduction
- Introduction
- Market Scope
- Market Definition
- Segments Covered
- Regional Segmentation
- Research Timeframe
- Currency Considered
- Study Limitations
- Stakeholders
- List of Abbreviations
- Key Conferences and Events (2025-2026)
- Research Methodology
- Secondary Research
- Primary Research
- Market Estimation
- Bottom-Up Approach
- Top-Down Approach
- Market Forecasting
- Executive Summary
- Apheresis Market Snapshot (2025-2030)
- Segment Overview
- Regional Snapshot
- Competitive Insights
- Market Overview
- Market Dynamics
- Drivers
- Rising incidence of hematologic and autoimmune disorders
- Growing awareness and participation in blood donation
- Increasing demand for blood components
- Advancements in apheresis technology
- Favorable reimbursement policies in developed countries
- Restraints
- High cost of apheresis procedures and equipment
- Limited availability of skilled professionals
- Regulatory complexities affecting market approval
- Opportunities
- Growth in personalized medicine and cell therapies
- Expansion of therapeutic applications beyond hematology
- Market expansion in developing regions with rising healthcare investments
- Key Market Trends
- Growing preference for selective and personalized apheresis
- Development of AI-integrated apheresis devices
- Unmet Market Needs
- Industry Speaks
- Drivers
- Market Dynamics
- Global Apheresis Market Size & Forecast (2023-2030), By Product, USD Million
- Introduction
- Devices
- Disposables & Consumables
- Global Apheresis Market Size & Forecast (2023-2030), By Procedure, USD Million
- Introduction
- Plasmapheresis
- Plateletpheresis
- Leukapheresis
- Photopheresis
- Erythrocytapheresis
- Others
- Global Apheresis Market Size & Forecast (2023-2030), By Technology, USD Million
- Introduction
- Centrifugation
- Membrane Separation
- Global Apheresis Market Size & Forecast (2023-2030), By Application, USD Million
- Introduction
- Renal Disorders
- Neurological Disorders
- Hematological Disorders
- Autoimmune Disorders
- Others
- Global Apheresis Market Size & Forecast (2023-2030), By End-user, USD Million
- Introduction
- Hospitals
- Blood Banks
- Specialty Clinics
- Others
- Global Apheresis Market Size & Forecast (2023-2030), By Region, USD Million
- Introduction
- North America Apheresis Market Size & Forecast (2023-2030), By Country, USD Million
- US
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Procedure (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Canada
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Procedure (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- US
- Europe Apheresis Market Size & Forecast (2023-2030), By Country, USD Million
- UK
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Procedure (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Germany
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Procedure (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- France
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Procedure (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Italy
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Procedure (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Spain
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Procedure (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Rest of Europe
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Procedure (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- UK
- Asia Pacific (APAC) Apheresis Market Size & Forecast (2023-2030), By Country, USD Million
- China
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Procedure (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Japan
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Procedure (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- India
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Procedure (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Rest of Asia Pacific
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Procedure (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- China
- Latin America (LATAM) Apheresis Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Procedure (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Middle East & Africa (MEA) Apheresis Market Size & Forecast (2023-2030), USD Million
- Market Size & Forecast, By Product (USD Million)
- Market Size & Forecast, By Procedure (USD Million)
- Market Size & Forecast, By Technology (USD Million)
- Market Size & Forecast, By Application (USD Million)
- Market Size & Forecast, By End-user (USD Million)
- Competitive Landscape
- Key Players and their Competitive Positioning
- Key Player Comparison
- Segment-wise Player Mapping
- Market Share Analysis (2024)
- Company Categorization Matrix
- Dominants/Leaders
- New Entrants
- Emerging Players
- Innovative Players
- Key Strategies Assessment, By Player (2022-2025)
- New Product Launches
- Partnerships, Agreements, & Collaborations
- Mergers & Acquisitions
- Geographic Expansion
- Key Players and their Competitive Positioning
- Company Profiles*
(Business Overview, Financial Performance**, Products Offered, Recent Developments)
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Asahi Kasei Medical Co., Ltd.
- Terumo BCT, Inc.
- Baxter International Inc.
- Becton, Dickinson and Company
- Medica S.p.A
- Braun Melsungen AG
- Mallinckrodt Plc
- Nikkiso Co., Ltd
- Other Prominent Players
Note: *Indicative list
**For listed companies
The study has been compiled based on extensive primary and secondary research.
Secondary Research (Indicative List)
Primary Research
To validate research findings (market size & forecasts, market segmentation, market dynamics, competitive landscape, key industry trends, etc.), extensive primary interviews were conducted with both supply and demand-side stakeholders.
Supply Side Stakeholders:
- Senior Management Level: CEOs, Presidents, Vice-Presidents, Directors, Chief Technology Officers, Chief Commercial Officers
- Mid-Management Level: Product Managers, Sales Managers, Brand Managers, R&D Managers, Business Development Managers, Consultants
Demand Side Stakeholders:
- Stakeholders from Hospitals, Blood Banks, Specialty Clinics and Others
Breakdown of Primary Interviews
Market Size Estimation
Both ‘Top-Down & Bottom-Up Approaches’ were used to derive market size estimates and forecasts
Data Triangulation
Research findings derived through secondary sources & internal analysis was validated with Primary Interviews, Internal Knowledge Repository and Company’s Sales Data
